The Centers for Medicare and Medicaid Services is planning a series of one-hour calls with drug manufacturers in the coming months to discuss implementation of the Medicare drug pricing reforms in the Inflation Reduction Act, starting with the price negotiation program.
The move may be an encouraging sign, because the IRA leaves a lot of details up to CMS to flesh...